Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)

K-Number: K233663 · 2023-12-13

Decision Date2023-12-13
Product CodeCFN
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is a medical device manufactured by Siemens Healthcare Diagnostics Products GmbH. It received FDA 510(k) clearance on 2023-12-13 under approval number K233663. The device is classified under product code CFN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is a medical device that received FDA 510(k) clearance on 2023-12-13. It is manufactured by Siemens Healthcare Diagnostics Products GmbH. The 510(k) number is K233663.

When was N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) approved by the FDA?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) received FDA 510(k) clearance on 2023-12-13, under approval number K233663.

What company makes N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is manufactured by Siemens Healthcare Diagnostics Products GmbH.

What is the FDA product code for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

The FDA product code for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is CFN.

Other Devices by Siemens Healthcare Diagnostics Products GmbH

View all 19 devices →

Related Devices (Code: CFN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.